MultiDrug resistance (MDR) is a complex phenomenon responsible for multiple cross-resistance towards structurally unrelated drugs and it characterizes almost 70% of solid and haematological tumours at the diagnosis.
New strategies to overcome resistance to chemotherapy and immune system in cancer
Riganti C.
First
;
2019-01-01
Abstract
MultiDrug resistance (MDR) is a complex phenomenon responsible for multiple cross-resistance towards structurally unrelated drugs and it characterizes almost 70% of solid and haematological tumours at the diagnosis.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Riganti, IJMS 2019.pdf
Accesso aperto
Descrizione: Riganti, IJMS 2019
Tipo di file:
PDF EDITORIALE
Dimensione
177.83 kB
Formato
Adobe PDF
|
177.83 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
